Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Kidney Neoplasms × vorolanib × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Carcinoma, Renal Cell 2 Kidney Neoplasms 1

Interventions

Pluvicto 2 zimberelimab 1 vorolanib 1 palbociclib 1 cabozantinib 1 Urination 1 Tumor Burden 1 Sunitinib 1 Radiosurgery 1 Nivolumab 1 Nephrectomy 1 Ipilimumab 1 Histocompatibility Testing 1 Blood Specimen Collection 1 Bariatric Surgery 1 Axitinib 1 Aminolevulinic Acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06577961 2024-08-29

Vorolanib Combined With Cadonilimab in the Treatment of Untreated Advanced RCC Patients

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Phase 1/2 Not yet recruiting

Carcinoma, Renal Cell, Kidney Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡